Investor Kelly Habbas disclosed an increased stake in WORK Medical Technology Group LTD in an amended Schedule 13G filing dated June 10, 2026. Habbas now beneficially owns 369,000 Class A Ordinary Shares. This position represents 21.5% of the company’s Class A shares.
The investor holds sole voting and dispositive power over the entire stake. This update follows an initial filing from early June 2026.
Habbas previously reported an 18.9% stake in the company. That initial position totaled 325,000 shares.
The Schedule 13G filing confirms this is a passive investment. These shares were not purchased to influence or change control of the medical device firm.